Correction to: Oncogene https://doi.org/10.1038/s41388-022-02280-3, published online 30 March 2022

In former Supplementary Fig. 6A, the top left panel was inadvertently mislabeled as “Control” when, in fact, corresponded to sEVHYP-exposed cells treated with the small molecule NFκB inhibitor, pXSC. The correct “Control” panel has now been included in a revised Supplementary Fig. 6A.

The original Supplementary Material has been corrected.